An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
Public ClinicalTrials.gov record NCT01168856. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-term Monitoring Study to Evaluate the Persistence of Direct Antiviral (DAA) Treatment Resistant Mutations or the Durability of Sustained Virological Response (SVR) in Patients Treated With DAA Containing Regimens for Chronic Hepatitis C Infections (CHC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This observational long-term follow-up study will assess the persistence of direct acting antiviral (DAA) resistant mutations and the durability of sustained virological response in patients with chronic hepatitis C who have participated in a Roche DAA treatment protocol. Up to 5 scheduled monitoring visits for blood sampling during an observational period of up to 36 months.
Study identification
- NCT ID
- NCT01168856
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 734 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2010
- Primary completion
- Mar 31, 2015
- Completion
- Mar 31, 2015
- Last update posted
- Mar 10, 2016
2010 – 2015
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | La Jolla | California | 92037-1030 | — |
| Not listed | Long Beach | California | 90822 | — |
| Not listed | Sacramento | California | 95817 | — |
| Not listed | Sacramento | California | 95825 | — |
| Not listed | San Diego | California | 92103-8465 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Englewood | Colorado | 80113 | — |
| Not listed | Bradenton | Florida | 34209 | — |
| Not listed | Atlanta | Georgia | 30309 | — |
| Not listed | Decatur | Georgia | 30033 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Honolulu | Hawaii | 96814 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Kansas City | Kansas | 66160-7222 | — |
| Not listed | New Orleans | Louisiana | 70112 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Kansas City | Missouri | 64131 | — |
| Not listed | Lebanon | New Hampshire | 03756 | — |
| Not listed | Hillsborough | New Jersey | 08844 | — |
| Not listed | Newark | New Jersey | 07102 | — |
| Not listed | Manhasset | New York | 11030 | — |
| Not listed | New York | New York | 10003 | — |
| Not listed | New York | New York | 10021 | — |
| Not listed | Providence | Rhode Island | 02905 | — |
| Not listed | Nashville | Tennessee | 37211 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | San Antonio | Texas | 78212 | — |
| Not listed | San Antonio | Texas | 78234 | — |
| Not listed | Newport News | Virginia | 23602 | — |
| Not listed | Richmond | Virginia | 23249 | — |
| Not listed | Vancouver | Washington | 98604 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01168856, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2016 · Synced Sep 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01168856 live on ClinicalTrials.gov.